Results 51 to 60 of about 3,822 (260)

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis

Zhongguo shuxue zazhi
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness.
ZHU Jianling, CHENG Tingting, MA Chunya, FU Lihui, SHI Hongmei, YU Yang   +5 more
doaj   +1 more source

Carrion's disease after blood transfusion [PDF]

, 2015
Bartonella bacilliformis is a pathogen that is endemic in some areas of the Andean region of Peru, southern Ecuador and southern Colombia. This pathogen causes so-called Carrion's disease, a biphasic disease with acute and chronic phases (called Oroya ...
Lovato, Pedro, Pons, Maria J., Ruiz, Joaquim, Silva, Jaquelyne, Urteaga, Numan, Valle Mendoza, Juana del   +5 more
core   +2 more sources

Refraktori Trombosit pada Ibu dengan Trombositopenia dalam Kehamilan [PDF]

, 2023
Pendahuluan: Refraktori trombosit selalu menjadi masalah pada pasien trombositopenia karena meningkatkan risiko perdarahan spontan yang dapat mengancam jiwa. Kondisi ini menjadi penyulit dalam terapi pasien trombositopenia dan perdarahan. Penyebab paling
Hikmah, Nurul, Subono, Riska
core   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Detection of platelet-associated immunoglobulins and complement system components in patients with aplastic anemia and hemoblastosis

Онкогематология, 2019
Background. In addition to anti-HLA-I and anti-HPA-antibodies and specific cytotoxic T-lymphocytes, another cause of immune refractoriness to donor's platelet transfusions could be a platelet-associated different classes immunoglobulins PAIg (G, M, A ...
A. F. Rakhmani, E. A. Mikhaylova, I. V. Galtseva, Yu. O. Davidova, N. M. Kapranov, I. V. Dubinkin, S. M. Kulikov, T. V. Gaponova, Z. T. Fidarova, V. V. Troitskaya, E. N. Parovichnikova, V. G. Savchenko   +11 more
doaj   +1 more source

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies [PDF]

Journal of Korean Medical Science, 1988
In thirty patients with acute leukemia and severe aplastic anemia receiving random single donor platelet transfusions, the development of refractoriness by consecutive platelet transfusions with cytapheresis and its relationship to the appearance of anti-platelet antibodies were investigated.
M, Lee, B K, Kim, S, Park, C, Suh, M H, Park, M J, Cho   +5 more
openaire   +2 more sources

Safety and Effectiveness of Uterine Gauze Packing for Refractory Postpartum Haemorrhage: A Systematic Review and Meta‐Analysis

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The role of uterine gauze packing in treating refractory postpartum haemorrhage (PPH) is uncertain given limited evidence of benefit and possible harms. Objectives To evaluate the safety and effectiveness of uterine packing using plain gauze or gauze impregnated with haemostatic agent(s) for treating refractory PPH.
Maureen Makama, Alicia Ferguson, Mairead Connolly, Sarah Boudova, Samia Aziz, Lorena Romero, Joshua P. Vogel   +6 more
wiley   +1 more source

Prevention and Management of Platelet Transfusion Refractoriness [PDF]

Vox Sanguinis, 1999
AbstractPlatelet transfusion refractoriness is a major complication of long‐term platelet supportive care. Refractoriness may lead to fatal bleeding complications in thrombocytopenic patients. Major factors involved are factors related to the clinical condition of the patient as well as HLA alloimmunisation. Non‐alloimmune factors may occur in up to 80%
openaire   +2 more sources

Platelet transfusions in hematological disorders [PDF]

, 2021
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with hematological disorders are at risk of bleeding and platelet transfusions are important in supportive care and treatment of lite-threatening bleedings ...
Karlström, Cecilia
core   +1 more source

Percutaneous Versus Surgical Cannulation for Femoro‐Femoral Venoarterial Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study on Cannulation‐Related Complications

Artificial Organs, EarlyView.
Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg, Magnus Dalén, Anders Franco‐Cereceda, Thomas Fux   +3 more
wiley   +1 more source